Pro MedicusPMDIY +18.61%73 PS Ratio is 96.03 as of Jul. 01, 2026, which is 55% above its 10-year median of 61.85. GuruFocus rates PMDIY with a GF Score™ of 73/100 and a GF Value™ of $40.42 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 659 Healthcare Providers & Services companies, Pro Medicus ranks worse than 98.48% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Pro Medicus's share price is $29.00.
Pro Medicus's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.30. Hence, Pro Medicus's PS Ratio for today is 96.03.
The historical rank and industry rank for Pro Medicus's PS Ratio or its related term are showing as below:
PMDIY'
s PS Ratio Range Over the Past 10 Years
Min: 16.16 Med: 61.85 Max: 185.35
Current: 97.49
During the past 13 years, Pro Medicus's highest PS Ratio was 185.35. The lowest was 16.16. And the median was 61.85.
PMDIY's PS Ratio is ranked worse than 98.48% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.49
vs PMDIY: 97.49
Pro Medicus Ltd has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Pro Medicus was 30.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 31.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 31.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 26.40% per year.
During the past 13 years, Pro Medicus's highest 3-Year average Revenue per Share Growth Rate was 34.20% per year. The lowest was -16.50% per year. And the median was 16.20% per year.
Back to Basics: PS Ratio
Pro Medicus (OTCPK:PMDIY) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Pro Medicus PS Ratio Related Terms
Pro Medicus PS Ratio Historical Data
* Premium members only.
The historical data trend for Pro Medicus's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Pro Medicus's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro Medicus PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's PS Ratio distribution charts can be found below:
* The bar in red indicates where Pro Medicus's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Pro Medicus's Share Price of today is $29.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pro Medicus's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.30.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Pro Medicus (PMDIY) has a PS Ratio of 96.03 as of Jul. 01, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Pro Medicus and its competitors. This is 55% above median its historical median of 61.85. Over the past decade, Pro Medicus' PS Ratio has ranged from 16.16 to 185.35. According to the industry distribution chart, Pro Medicus ranks #649 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 98.5%.
Is Pro Medicus' PS Ratio too high?
Pro Medicus' current PS Ratio of 96.03 is 55% above median its 10-year median of 61.85. Over the past 10 years, this metric has ranged from a low of 16.16 to a high of 185.35. The Healthcare Providers & Services industry median PS Ratio is 1.49. Pro Medicus' value of 96.03 is 6345% above this industry median. Based on the distribution chart, Pro Medicus ranks #649 out of 659 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pro Medicus has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #649 out of 659 companies for PS Ratio. This places Pro Medicus in the lower half of its industry. The industry median PS Ratio is 1.49. Pro Medicus' value of 96.03 is 6345% above this benchmark. Historically, Pro Medicus' own PS Ratio has ranged from 16.16 to 185.35 over the past decade. While the company's 10-year median is 61.85 vs. the industry median of 1.49, Pro Medicus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.49, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro Medicus's current PS Ratio of 96.03 is 6345% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Pro Medicus and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro Medicus's current PS Ratio is 96.03, which is 55% above median its own 10-year median of 61.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Modestly Undervalued. The stock's GF Value™ is $40.42, compared to a current price of $29.00 — trading 28.3% below its estimated fair value. The current PS Ratio is 96.03, which is 55% above median its 10-year median of 61.85 and 6345% above the Healthcare Providers & Services industry median of 1.49. Pro Medicus' overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current PS Ratio is 96.03 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro Medicus (PMDIY) Overvalued in 2026?
Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued.
The current stock price of $29.00 is trading 28.3% below its estimated GF Value™ of $40.42.
GuruFocus considers Pro Medicus to be Modestly Undervalued.
Key valuation signals for PMDIY:
PS Ratio: 96.03 (55% above median its 10-year median of 61.85)
GF Value™: $40.42 vs. price of $29.00 (28.3% below fair value)
Industry Position: 6345% above the Healthcare Providers & Services median (#649 of 659)
No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
73GF Score
Get the complete analysis for PMDIY
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMDIY has been successfully added to your 
